Key facts
- This page summarizes Eric Venker's Form 3 filing for Roivant Sciences Ltd. (ROIV).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 01 Oct 2021, 17:38.
Eric Venker - 01 Oct 2021 Form 3 Insider Report for Roivant Sciences Ltd. (ROIV)
- Reporting relationship
- President & COO
- Issuer ticker
- ROIV
- Reported as of
- 01 Oct 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 01 Oct 2021, 17:38:59 UTC
- Next SEC filing
- 29 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Venker filed Form 3 for Roivant Sciences Ltd. (ROIV) on 01 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ROIV
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,388,993
- Date
- 01 Oct 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 260,326
- Exercise price
- $7.45
- Footnotes
- F2, F8
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 70,702
- Exercise price
- $7.99
- Footnotes
- F3, F8
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 292,620
- Exercise price
- $10.96
- Footnotes
- F4, F8
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 1,181,883
- Exercise price
- $15.85
- Footnotes
- F5, F8
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 438,930
- Exercise price
- $13.07
- Footnotes
- F6, F8
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 1,969,557
- Exercise price
- $10.00
- Footnotes
- F7, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Includes (i) an award of 438,930 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of May 20, 2020 and (ii) an award of 950,063 RSUs with a vesting commencement date of May 20, 2021. These awards of RSUs service-vest (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.
Footnote F2
Award of stock options to purchase Common Shares with a vesting commencement date of October 16, 2017.
Footnote F3
Award of stock options to purchase Common Shares with a vesting commencement date of May 21, 2018.
Footnote F4
Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2019.
Footnote F5
Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019.
Footnote F6
Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2020.
Footnote F7
Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2021.
Footnote F8
Awards of stock options to purchase Common Shares vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.
SEC remarks
Exhibit 24 - Power of Attorney